ROLE OF INDIVIDUAL MICROELEMENTS AND VITAMINS IN HASHIMOTO'S DISEASE

Authors

DOI:

https://doi.org/10.21856/j-PEP.2024.3.07

Keywords:

Hashimoto's disease, micronutrients, vitamins, pathophysiology, supplementation, review

Abstract

Introduction and objective. Hashimoto's disease is a chronic autoimmune thyroiditis. The chronic process of this disease leads to hypothyroidism. Various micronutrients and vitamins play an important role in the course of the disease and may have a significant impact on the development and treatment of Hashimoto's disease. The aim of this study is to review the literature to fully assess the impact of micronutrients on symptoms, prognosis and dynamics of change in the context of Hashimoto's disease. Articles were searched by entering keywords in PubMed databases. Scientific articles covering the period from 2016 to 2024 represent 76% of the items included in the literature. Studies from specialized research centers including meta-analyses, double-blinded randomized trials, large cross-sectional studies were considered. Studies from inexperienced centers with methodological flaws were discarded.

Abbreviated description of the state of knowledge. Current treatment of clinically overt hypothyroidism is based on the use of levothyroxine. The dose of substitution treatment is determined individually for the patient depending on the symptoms observed, TSH values and age. Currently, there are no recommendations for supplementation of microelements for the disease, which is due to the need to expand research and determine which micronutrients are worth taking to increase the quality of life of patients.

Conclusion. The number of cases of Hashimoto's disease is steadily increasing worldwide. Increasing attention is being paid to elements of the patient's diet and environment, in addition to the substitution treatment itself. The modification of a broadly defined lifestyle and the influence of environmental factors may in the near future find a place in the standard therapeutic management of patients with chronic autoimmune thyroiditis.

References

Ragusa F, Fallahi P, Elia G, et al. Best Pract Res Clin Endocrinol Metab 2019;33(6): 101367. http://doi.org/10.1016/j.beem.2019.101367

Ralli M, Angeletti D, Fiore M, et al. Autoimmun Rev 2020;19(10): 102649. http://doi.org/10.1016/j.autrev.2020.102649

Ajjan RA, Weetman AP. Horm Metab Res 2015;47(10): 702-710. http://doi.org/10.1055/s-0035-1548832

Bliddal S, Nielsen CH, Feldt-Rasmussen U. F1000Res 2017;6: 1776. http://doi.org/10.12688/f1000research.11535.1

Song RH, Yao QM, Wang B, et al. Autoimmun Rev 2019;18(10): 102368. http://doi.org/10.1016/j.autrev.2019.102368

Yao Q, Song Z, Wang B, et al. Autoimmun Rev 2019;18(6): 634-636. http://doi.org/10.1016/j.autrev.2019.01.003

Mynster Kronborg T, Frohnert Hansen J, Nielsen CH, et al. PLoS One 2016;11(4): e0154621. http://doi.org/10.1371/journal.pone.0154621

Song RH, Yu ZY, Qin Q, et al. Int J Clin Exp Pathol 2014;7(7): 4024-4031.

Wang S, Baidoo SE, Liu Y, et al. Clin Exp Immunol 2013;171(1): 63-68. http://doi.org/10.1111/j.1365-2249.2012.04670.x

Gong B, Wang C, Meng F, et al. Front Endocrinol (Lausanne) 2021;12: 774362. http://doi.org/10.3389/fendo.2021.774362

WHO Guideline: Fortification of Food-Grade Salt with Iodine for the Prevention and Control of Iodine Deficiency Disorders, Geneva, 2014: 1-54.

Krela-Kaźmierczak I, Czarnywojtek A, Skoracka K, et al. Nutrients 2021;13(2): 513. http://doi.org/10.3390/nu13020513

Luo Y, Kawashima A, Ishido Y, et al. Int J Mol Sci 2014;15(7): 12895-12912. http://doi.org/10.3390/ijms150712895

Xu C, Wu F, Mao C, et al. J Autoimmun 2016;75: 50-57. http://doi.org/10.1016/j.jaut.2016.07.008

Teti C, Panciroli M, Nazzari E, et al. Immunol Res 2021;69(2): 129-138. http://doi.org/10.1007/s12026-021-09192-6

Kieliszek M, Błażejak S. Molecules 2016;21(5): 609. http://doi.org/10.3390/molecules21050609

Duntas LH, Benvenga S. Endocrine 2015;48(3): 756-775. http://doi.org/10.1007/s12020-014-0477-6

Wang F, Li C, Li S, et al. Front Endocrinol (Lausanne) 2023;14: 1133000. http://doi.org/10.3389/fendo.2023.1133000

Xu J, Liu XL, Yang XF, et al. Biol Trace Elem Res 2011;141(1-3): 110-118. http://doi.org/10.1007/s12011-010-8728-8

Ventura M, Melo M, Carrilho F. Int J Endocrinol 2017;2017: 1297658. http://doi.org/10.1155/2017/1297658

Krysiak R, Okopien B. J Clin Endocrinol Metab 2011;96(7): 2206-2215. http://doi.org/10.1210/jc.2010-2986

Winther KH, Papini E, Attanasio R, et al. Eur Thyroid J 2020;9(2): 99-105. http://doi.org/10.1159/000504781

Rostami R, Nourooz-Zadeh S, Mohammadi A, et al. Antioxidants (Basel) 2020;9(11): 1070. http://doi.org/10.3390/antiox9111070

Wang LF, Sun RX, Li CF, Wang XH. Endokrynol Pol 2021;72(6): 666-667. http://doi.org/10.5603/EP.a2021.0074

Tian X, Li N, Su R, et al. Int J Endocrinol 2020;2020: 9210572. http://doi.org/10.1155/2020/9210572

Kryczyk-Kozioł J, Zagrodzki P, Prochownik E, et al. Int J Clin Pract 2021;75(9): e14484. http://doi.org/10.1111/ijcp.14484

Pirola I, Rotondi M, Cristiano A, et al. Endocrinol Diabetes Nutr (Engl Ed) 2020;67(1): 28-35. http://doi.org/10.1016/j.endinu.2019.03.018

Hu Y, Feng W, Chen H, et al. Clin Transl Sci 2021;14(4): 1390-1402. http://doi.org/10.1111/cts.12993

Esposito D, Rotondi M, Accardo G, et al. J Endocrinol Invest 2017;40(1): 83-89. http://doi.org/10.1007/s40618-016-0535-4

Wessels I, Maywald M, Rink L. Nutrients 2017;9(12): 1286. http://doi.org/10.3390/nu9121286

Severo JS, Morais JBS, de Freitas TEC, et al. Int J Vitam Nutr Res 2019;89(1-2): 80-88. http://doi.org/10.1024/0300-9831/a000262

Prasad AS, Bao B. Antioxidants (Basel) 2019;8(6): 164. http://doi.org/10.3390/antiox8060164

Mocchegiani E, Malavolta M, Costarelli L, et al. Curr Aging Sci 2013;6(1): 99-107. http://doi.org/10.2174/1874609811306010013

Mahmoodianfard S, Vafa M, Golgiri F, et al. J Am Coll Nutr 2015;34(5): 391-399. http://doi.org/10.1080/07315724.2014.926161

Schwalfenberg GK, Genuis SJ. Scientifica (Cairo) 2017;2017: 4179326. http://doi.org/10.1155/2017/4179326

Wang K, Wei H, Zhang W, et al. Sci Rep 2018;8(1): 9904. http://doi.org/10.1038/s41598-018-28362-5

Luo Y, Zeng H, Ye Y, et al. Environ Sci Pollut Res Int 2023;30(8): 21072-21080. http://doi.org/10.1007/s11356-022-23625-1

Aspuru K, Villa C, Bermejo F, et al. Int J Gen Med 2011;4: 741-750. http://doi.org/10.2147/IJGM.S17788

Starchl C, Scherkl M, Amrein K. Nutrients 2021;13(6): 1755. http://doi.org/10.3390/nu13061755

Rayman MP. Proc Nutr Soc 2019;78(1): 34-44. http://doi.org/10.1017/S0029665118001192

Koç Ş, Güngör K, Dokuzeylül Güngör N, et al. J Exp Clin Med 2022;39(1): 194-198.

Luo J, Wang X, Yuan L, Guo L. Front Endocrinol (Lausanne) 2021;12: 629831. http://doi.org/10.3389/fendo.2021.629831

Schmid A, Walther B. Adv Nutr 2013;4(4): 453-462. http://doi.org/10.3945/an.113.003780

Maciejewski A, Wójcicka M, Roszak M, et al. Adv Clin Exp Med 2015;24(5): 801-806. http://doi.org/10.17219/acem/29183

Fang F, Chai Y, Wei H, et al. Endocrine 2021;73(2): 447-454. http://doi.org/10.1007/s12020-021-02688-z

Xu J, Zhu XY, Sun H, et al. BMC Endocr Disord 2018;18(1): 87. http://doi.org/10.1186/s12902-018-0314-7

Cvek M, Kaličanin D, Barić A, et al. Nutrients 2021;13(8): 2793. http://doi.org/10.3390/nu13082793

Nodehi M, Ajami A, Izad M, et al. Eur J Clin Nutr 2019;73(9): 1236-1243. http://doi.org/10.1038/s41430-019-0395-z

Benites-Zapata VA, Ignacio-Cconchoy FL, Ulloque-Badaracco JR, et al. Front Endocrinol (Lausanne) 2023;14: 1070592. http://doi.org/10.3389/fendo.2023.1070592

Obeid R, Heil SG, Verhoeven MMA, et al. Front Nutr 2019;6: 93. http://doi.org/10.3389/fnut.2019.00093

Aktaş HŞ. Med Princ Pract 2020;29(4): 364-370. http://doi.org/10.1159/000505094

Szczepanek-Parulska E, Hernik A, Ruchała M. Pol Arch Intern Med 2017;127(5): 352-360. http://doi.org/10.20452/pamw.3985

Kacharava T, Giorgadze E, Janjgava S, et al. Endocr Metab Immune Disord Drug Targets 2023;23(1): 86-94. http://doi.org/10.2174/1871530322666220627145635

Downloads

Published

2024-09-15

How to Cite

Kowalewski, J., Dąbrowska, A., Pyc, G., Bęben, D., Dudzik, M., Majewski, K., … Mączka, J. (2024). ROLE OF INDIVIDUAL MICROELEMENTS AND VITAMINS IN HASHIMOTO’S DISEASE. Problems of Endocrine Pathology, 81(3), 53–60. https://doi.org/10.21856/j-PEP.2024.3.07

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.